Long noncoding RNA expressing genomic elements that control antibody diversification and chromosomal integrity in B cells

表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA

基本信息

  • 批准号:
    10531294
  • 负责人:
  • 金额:
    $ 58.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-07 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Background. It is now evident that the majority of the mammalian genome has the potential to express non- coding RNAs (ncRNAs). However, the functionality and mechanism(s) of regulation of these ncRNAs are just beginning to be explored. One challenge that biologists encounter is the detection of these ncRNAs, which often tend to be transcriptionally tightly controlled and rapidly degraded. Using mouse models that allow easy detection of lncRNA, we have recently identified a set of long noncoding RNAs (lncRNA) that are expressed surrounding the immunoglobulin loci genes. These lncRNAs are placed inside topologically associating domains (TADs) that are formed during B cell development. Experiments using mouse models that lack these lncRNAs (published and preliminary data) demonstrate roles in class switch recombination and somatic hypermutation mechanisms. Objectives/Hypothesis. Here we investigate the direct role of lncRNAs in regulating genome local architecture and DNA topology via cis and trans mechanisms. In aim 1: we evaluate the physiological role of lncRNA-expressing loci in regulating IgH recombination via organizing TADIgH; in aim 2, we understand the molecular mechanisms through which lncRNAs are used to control genome architecture; and in aim 3, we focus on understanding the function of lncRNA SµGLT in control of CSR. Study Design: Using mouse models and cell lines that are deficient in specific lncRNAs we aim to investigate their immunologically relevant functions. For evaluating the molecular mechanism of action of the lncRNAs we use biochemical assays to purify lncRNA interacting proteins and perform chromosomal architecture assays such as HiC and 4C-seq. Finally, we perform high-throughput sequencing experiments to evaluate the lncRNA's effect(s) on SHM in the Ig loci genes and elsewhere. Disease Relevance: The proposed studies will lead to a better understanding of the mechanisms in B cell development and function. The lncRNAs being investigated in this application carry polymorphisms in patients with IgA deficiency syndrome and thus our study is relevant for human physiology. Finally, antibody diversification mechanisms are essential for immune system homeostasis but when these mechanisms fail there are increased genomic alterations that are associated with lymphomas. Thus, this study is related with both immunity and lymphomagenesis.
项目摘要 背景现在很明显,大多数哺乳动物基因组具有表达非- 编码RNA(ncRNA)。然而,这些ncRNA的功能和调节机制仅仅是 开始被探索。生物学家遇到的一个挑战是检测这些ncRNA, 往往在转录上受到严格控制并迅速降解。使用鼠标模型, 为了检测lncRNA,我们最近鉴定了一组长的非编码RNA(lncRNA),它们表达于 围绕着免疫球蛋白基因座的基因。这些lncRNA被放置在拓扑关联的 在B细胞发育过程中形成的TADs。使用缺乏这些的小鼠模型进行的实验 lncRNA(已发表和初步数据)在类转换重组和体细胞重组中发挥作用 超突变机制 目标/假设。在这里,我们研究lncRNA在调节基因组局部中的直接作用 结构和DNA拓扑结构通过顺式和反式机制。在目标1中:我们评估了 lncRNA表达位点通过组织TADIgH调节IgH重组;在目标2中,我们了解了 lncRNA用于控制基因组结构的分子机制;在目标3中,我们 重点了解lncRNA SµGLT在控制CSR中的功能。 研究设计:使用缺乏特异性lncRNA的小鼠模型和细胞系,我们旨在研究 免疫相关功能。为了评估lncRNA的分子作用机制,我们 使用生物化学分析来纯化lncRNA相互作用蛋白,并进行染色体结构分析 例如HiC和4C-seq。最后,我们进行了高通量测序实验,以评估 lncRNA在IG基因座基因和其他地方对SHM的影响。 疾病相关性:拟议的研究将有助于更好地了解B细胞中的机制。 发展和功能。本申请中研究的lncRNA在患者中携带多态性 伊加缺乏综合征,因此我们的研究与人类生理学有关。最后,抗体 多样化机制对于免疫系统的稳态是必不可少的,但当这些机制失败时, 与淋巴瘤相关的基因组改变增加。因此,本研究与 免疫力和淋巴瘤的发生

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Uttiya Basu其他文献

Uttiya Basu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Uttiya Basu', 18)}}的其他基金

FASEB's "The RNA Associated Mechanisms Conference: In Immunity and Disease"
FASEB 的“RNA 相关机制会议:免疫与疾病”
  • 批准号:
    9993686
  • 财政年份:
    2021
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10461710
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    9897023
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10721410
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10259665
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10598241
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10682918
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10683111
  • 财政年份:
    2020
  • 资助金额:
    $ 58.96万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10303057
  • 财政年份:
    2017
  • 资助金额:
    $ 58.96万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10065485
  • 财政年份:
    2017
  • 资助金额:
    $ 58.96万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 58.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了